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Mitochondrial permeability transitiona b s t r a c t
The sydnone SYD-1 (3-[4-chloro-3-nitrophenyl]-1,2,3-oxadiazolium-5-olate] possesses important antitu-
mor activity against Sarcoma 180 and Ehrlich tumors. We previously showed that SYD-1 depresses mito-
chondrial phosphorylation efﬁciency, which could be involved in its antitumoral activity. Considering the
important role of mitochondria in the generation of reactive oxygen species (ROS) and the involvement of
ROS in cell death mechanisms, we evaluated the effects of SYD-1 on oxidative stress parameters in rat
liver mitochondria. SYD-1 (0.5 and 0.75 lmol mg1 protein) inhibited the lipoperoxidation induced by
Fe3+/ADP-oxoglutarate by approximately 75% and promoted total inhibition at the highest concentration
tested (1.0 lmol mg1 protein). However, SYD-1 did not affect lipoperoxidation started by peroxyl radi-
cals generated by a-a0-azodiisobutyramidine dihydrochloride. The mesoionic compound (0.25–
1.0 lmol mg1 protein) demonstrated an ability to scavenge superoxide radicals, decreasing their levels
by 9–19%. The activities of catalase and superoxide dismutase did not change in the presence of SYD-1
(0.25–1.0 lmol mg1 protein). SYD-1 inhibited mitochondrial swelling dependent on the formation/
opening of the permeability transition pore induced by Ca2+/phosphate by approximately 30%
(1.0 lmol mg1 protein). When Ca2+/H2O2 were used as inducers, SYD-1 inhibited swelling only by
approximately 12% at the same concentration. NADPH oxidation was also inhibited by SYD-1
(1.0 lmol mg1 of protein) by approximately 48%. These results show that SYD-1 is able to prevent oxi-
dative stress in isolated mitochondria and suggest that the antitumoral activity of SYD-1 is not mediated
by the increasing generation of ROS.
 2013 Elsevier Ireland Ltd. All rights reserved.1. Introduction
The potential biological activities of mesoionic compounds,
which are associated with their chemical properties, have moti-
vated the synthesis of several mesoionic compounds within the
last few decades [1–4]. These compounds possess a ﬁve member
heterocyclic ring that cannot be represented by a covalent or polar
structure. The negative charge present in an atom or an exocyclic
group with which the ring associates is balanced by the positively
charged ring, resulting in an overall neutral molecule. These prop-
erties allow mesoionic compounds to cross biological membranes
and to interact with biomolecules such as DNA and proteins [4].
Several biological activities have been attributed to different
classes of mesoionic compounds (sydnones, sydnonymines, and
mesoionic 1,3,4-thiadiazoles); these activities include anti-inﬂam-
matory, analgesic, antibacterial [3,5–7], antiplatelet, ﬁbrinolytic
and thrombolytic activities, as well as broncholytic and antitumor
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chloro-3-nitrophenyl]-1,2,3-oxadiazolium-5-olate) (Fig. 1) has
shown important cytotoxic and antitumor effects in vivo [10–11].
However, the molecular mechanisms involved in these effects are
not known. In vitro studies suggest that alterations to the
permeability of mitochondrial membranes and the consequent
alteration of functions linked to energy provision may be involved
in the mechanisms of cell death induction, particularly apoptosis
[12]. We have shown that SYD-1 was able to promote both an
important inhibition of the respiratory chain as well as the
uncoupling of oxidative phosphorylation [13].
Several studies have shown that electron transport chain inhib-
itors can induce ROS overproduction and promote apoptosis
(intrinsic pathway) in tumor cells [14–16]. The key event in this
process is the permeabilization of the mitochondrial membrane
and the release of pro-apoptotic factors into the cytoplasm. These
pro-apoptotic factors can activate caspases responsible for the pro-
cess of cell death. The disruption of the mitochondrial membrane is
usually caused by BAX activation or calcium-mediated permeabil-
ity transition pore formation. These events are normally accompa-
nied by the dissipation of the mitochondrial membrane potential
[17]. It has been demonstrated that lipid peroxidation, a process
that can be initiated by oxidative stress, promotes mitochondrial
membrane permeabilization and induces apoptosis through the
modulation of PTP constituents [18].
To contribute to the understanding of the molecular pathways
involved in the biological action of SYD-1, we investigated in this
work the effects of SYD-1 on redox parameters that may be related
to the mitochondrial dysfunction, cytotoxicity and antitumoral
activity previously attributed to this mesoionic compound.2. Materials and methods
2.1. Chemicals
D-mannitol, HEPES, EGTA, rotenone, BSA, glutamic acid, ADP,
NADH, NBT, PMS, BHT and succinic acid were obtained from Sigma.
Monobasic potassium phosphate and trichloroacetic acid were ob-
tained from Synth. AAPH was purchased from Fluka. All other
chemicals used were of the highest commercially available purity.
SYD-1 was synthesized by the Department of Chemistry of the Fed-
eral Rural University of Rio de Janeiro, Brazil and its structure was
conﬁrmed by 1H NMR, 13C NMR and mass spectrometry [10]. For
use in assays, the compound was dissolved in DMSO and then fur-
ther diluted with the assay medium. The mesoionic compound was
incubated for two min with mitochondrial preparations before as-
says began. To validate each assay, duplicate controls with DMSO
were included at the concentrations used in the experiments.
DMSO had no effect on the parameters analyzed.
2.2. Animals
Male Wistar rats (180–200 g) were obtained from the Central
Animal House of Federal University of Paraná (PR, Brazil). They
were housed at 22 ± 1 C under a 12 h light – 12 h dark cycle (lightsFig. 1. Chemical structure of 3-[4-chloro-3-nitrophenyl]-1,2,3-oxadiazolium-5-
olate] (SYD-1).on at 08:00 h) with free access to standard laboratory food (Puri-
na) and tap water. The animals were starved for 12 h and then
killed by decapitation. Experiments were conducted following
the recommendations of Brazilian Law 11.794, 08/10/2008 for
the scientiﬁc management of animals and procedures and were ap-
proved by the institution’s Animal Ethics Committee.
2.3. Isolation of rat liver mitochondria
Mitochondria were isolated from rat liver by differential centri-
fugation [19] using an extraction medium consisting of 250 mM D-
mannitol, 10 mM HEPES–KOH (pH 7.2), 1 mM EGTA, and 0.1% BSA.
Speciﬁcally for mitochondrial permeability transitions and the oxi-
dation of pyridine nucleotides induced by calcium the last centri-
fugation was performed in the absence of EGTA. Disrupted
mitochondria were obtained by freeze–thawing and were used to
determine Mn-SOD activity.
2.4. Oxygen uptake
Oxygen uptake of intact mitochondria was evaluated at 28 C in
a 1.3 mL closed, thermostatically controlled water-jacketed cham-
ber under magnetic stirring. Oxygen consumption was measured
polarographically using a Clark-type electrode connected to a Gil-
son oxygraph [20–21] and a standard medium containing
125 mM D-mannitol, 65 mM KCl, 10 mM HEPES–KOH (pH 7.2)
and 0.1% BSA. The medium was supplemented with 1.0 mM Pi,
0.1 mM ADP, 5 mM sodium glutamate, 0.5 mM sodium malate
and 1.5 mg mL1 of mitochondrial protein. State 3 and 4 respira-
tion rates were measured after the addition of substrates in the
presence (state 3) and after exhaustion (state 4) of ADP. The respi-
ratory control coefﬁcient was calculated as the ratio of state 3 res-
piration to state 4 respiration [22]. Only mitochondrial
preparations with respiratory controls above 4 were used (data
not shown).
2.5. Determination of lipoperoxidation
Two systems were used as inducers of lipoperoxidation in intact
mitochondria. One system consisted of AAPH, an inducer of free
radicals in an aqueous phase at a concentration of 30 mM [23],
and the other system consisted of 2 mM ADP, 0.2 mM FeCl3 and
5 mM 2-oxoglutarate [24], which is able to induce the production
of free radicals from the respiratory chain. Lipoperoxidation was
performed as described by Buege and Aust [25] in medium con-
taining mitochondrial protein (1 mg mL1), 10 mM HEPES (pH
7.2), 250 mM mannitol and a system inducer of free radicals. Lipid
peroxidation was estimated by the absorbance of TBARS (e535 -
= 1.56  105 M1 cm1) and expressed as a percentage of control.3
2.6. Superoxide radical assay
The scavenging of superoxide radicals was assessed by the
method described by Nishimiki et al. [26], with some modiﬁca-
tions. The reaction mixture consisted of 10 mM Tris–HCl (pH
8.0), 70 lM NADH, 21 lM NBT and 9 lM PMS. The reaction was
followed at 560 nm for 1 min and the scavenging of superoxide
radicals was calculated using the following equation [27]:
Scavenging effect ¼ 1 Abs sample
Abs control
 2.7. Determination of mitochondrial permeability transition
The mitochondrial permeability transition was followed by ana-
lyzing the decrease in absorbance at 540 nm due to mitochondrial
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ability transition pore (PTP) induced by calcium [28]. The reaction
medium consisted of 250 mM D-mannitol, 10 mM HEPES (pH 7.2),
5 lM rotenone, 0.5 mg mL1 mitochondrial protein and 40–50 lM
CaCl2. The ﬁnal reaction volume (1 mL) was maintained at 28 C.
Swelling was initiated by the addition of 3 mM potassium succi-
nate and 0.3 mM potassium phosphate or 5 lMH2O2. Maximal ex-
tent of swelling was determined after 10 and 15 min of reaction,
when the inducers were Ca2+/Pi and Ca2+/H2O2, respectively. Indi-
vidual additions of 1 mM EGTA and 0.5 lM CsA, the latter a well-
known inhibitor of mitochondrial permeability transition [29],
were performed to conﬁrm that the swelling observed was due
to the formation of PTP.2.8. Determination of the redox state of mitochondrial NADPH
The redox state of mitochondrial NADPH was monitored by
ﬂuorimetry as recommended by Pigoso et al. [30]. The reaction
system consisted of 125 mM sucrose, 65 mM KCl and 10 mM
HEPES–KOH (pH 7.4). The medium was supplemented with
2.5 lM rotenone, 1 mg mL1 of mitochondrial protein and
40–50 lM CaCl2. The reaction occurred at 30 C and was initiated
by adding 5 mM succinate potassium. Excitation and emission
wavelengths of 366 and 450 nm were used, respectively (slit
5.0 nm).2.9. Determination of antioxidant enzymes
Catalase activity was accompanied by a decrease in absorbance
at 240 nm as proposed by Aebi [31]. In these assays, to ensure that
there was no contamination of cytoplasmic CAT, the mitochondrial
suspension was puriﬁed by ultracentrifugation at 40,000g for 1 h
with 30% v/v Percoll. The mitochondrial suspension was collected
at a relative density of 1070–1100 g/mL and two additional centrif-
ugations were performed at 8100g for 10 min at 4 C [32]. The
reaction system consisted of 50 mM phosphate buffer (pH 7.0)
and 0.5 mg/mL of mitochondrial protein. The reaction was initiated
by the addition of 10 mMH2O2 and monitored for 60 s at 25 C. The
results were expressed as U, where 1 U corresponds to 1 lmol of
H2O2 decomposed by protein milligram min1, considering a
extinction coefﬁcient of 39.4 M1 cm1. The Mn-SOD activity was
assessed according to the method proposed by Nishikimi et al.
[26] in disrupted mitochondria. The reaction system was main-
tained at 25 C and consisted of 10 mM TRIS–HCl (pH 8.0), 70 lM
NADH, 21 lM NBT, 9 lM PMS and an amount of mitochondrial
protein sufﬁcient to inhibit the reduction of NBT by 50%. The reac-
tion was initiated by the addition of NADH and monitored at
560 nm for 1 min. The results were expressed as percentages rela-
tive to the control, where one unit of Mn-SOD corresponded to 50%
inhibition of NBT reduction. To inactivate other SOD isoforms, sam-
ples were incubated with 6 mM KCN for 60 min at 0 C [33].Fig. 2. Effects of SYD-1 on lipid peroxidation. (A) The incubation system containing
250 mM D-mannitol, 10 mM HEPES (pH 7.2), 0.2 mM FeCl3, 2 mM ADP, and
1 mg mL1 mitochondrial protein was kept under stirring conditions at 37 C. The
reaction was initiated by the addition of 6 mM 2-oxoglutarate in the absence
(control) and presence of SYD-1 at the concentrations indicated, or in the absence of
FeCl (negative control). (B) The incubation system containing 250 mM D-mannitol,2.10. Protein determination
Protein concentrations were determined by the method de-
scribed by Lowry et al. [34].3
10 mM HEPES (pH 7.2) and 1 mg mL1 mitochondrial protein was kept under
stirring conditions at 37 C. The reaction was initiated by the addition of 30 mM
AAPH in the absence (control) and presence of SYD-1 at the concentrations
indicated, or in the absence of AAPH (negative control). Both reactions were
stopped after 45 min by the addition of 0.012% BHT. 100% values correspond to
6.23 ± 0.66 and 2.76 ± 0.2 nmol (mean ± SD) of TBARS per milligram of mitochon-
drial protein from three independent experiments. ⁄ Signiﬁcantly different from
control or between concentrations (P < 0.05).2.11. Statistical analysis
The data were statistically analyzed by variance analysis (ANO-
VA) and by Tukey’s test for average comparison. Mean values ± S.D.
were used; values were considered signiﬁcant when P < 0.05.3. Results
3.1. Effects of SYD-1 on lipoperoxidation in mitochondria
To check lipoperoxidation in isolated mitochondria, two differ-
ent methodologies were used. In the ﬁrst, lipoperoxidation was in-
duced by iron in mitochondria that were actively oxidizing
substrate. In this case, the respiratory chain was responsible for
the production of O2 and OH by the Fenton reaction [35]. Thus,
alterations to electron transport may reﬂect lipoperoxidation val-
ues. The positive control (with iron addition) (Fig. 2A) represents
the maximum amount of TBARS produced when iron is added to
the system. The negative control (without iron addition) shows
the basal level of mitochondrial lipoperoxidation (Fig. 2A). SYD-1
at a lower concentration (0.25 lmol mg1 protein) does not affect
lipoperoxidation. However, at intermediate concentrations (0.5
and 0.75 lmol mg1 protein), the mesoionic compound strongly
decreased lipoperoxidation by approximately 75%, reaching total
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relation to controls (Fig. 2A).
Fig. 2B shows the results of mitochondrial lipid peroxidation
initiated by alkyl radicals resulting from the decomposition of
the azo compound AAPH [23]. In this assay, mitochondria were
incubated in the absence of an oxidizable substrate. There was
no signiﬁcant alteration in peroxidation in comparison to the con-
trol. These results suggest that the inhibitory effect of SYD-1 on
lipoperoxidation is a result of its uncoupling action on oxidative
phosphorylation, which could promote an increase in the electron
transport rate and consequently a decrease in the generation of
superoxide anions and hydroxyl radicals [36], the latter of which
are the primary initiator of the lipoperoxidation process.
3.2. Scavenging capacity of SYD-1
Considering the inhibitory effect of SYD-1 on iron-induced lipo-
peroxidation, we decided to evaluate whether SYD-1 was capable
of scavenging O2. For this experiment, the non-enzymatic system
PMS/NADPH was used as an O2 generator in a mitochondria-free
assay. Fig. 3 shows that SYD-1 (0.25, 0.50, 0.75 and 1.0 lmol mL1)
was able to scavenge approximately 9%, 14%, 13% and 19% of the
available O2, respectively. This scavenging ability of SYD-1 may
contribute to its inhibition in iron-induced lipoperoxidation, which
was total at the highest concentration used (1.0 lmol mL1 in
Fig. 2A).
3.3. Effects of SYD-1 on mitochondrial antioxidant enzymes
Alterations of the activity of the enzymes SOD and CAT may
indirectly inﬂuence Fenton’s reaction and consequently control
OH formation [37]. SYD-1 did not promote signiﬁcant alterations
to the activity of these enzymes (data not shown).
3.4. Effects of SYD-1 on mitochondrial permeability transition
ROS generation is one of the primary factors contributing to the
opening/formation of PTP [38]. Considering that SYD-1 impairsFig. 3. Effects of SYD-1 on superoxide radical scavenging. The incubation system
containing 10 mM TRIS–HCl (pH 8), 70 lM NADH, 21 lM NBT, and 9 lM PMS was
kept at 25  C. The reaction was initiated by the addition of NADH and monitored at
560 nm for one min in the absence (control) and presence of SYD-1 at the
concentrations indicated. Values are expressed as percentages of superoxide
radicals scavenged, where each value represents the mean ± SD of three indepen-
dent experiments. ⁄ Signiﬁcantly different from control or between concentrations
(P < 0.05).mitochondrial bioenergetics [13], which could promote an increase
in ROS levels, we evaluate its effects on PTP using calcium/phos-
phate and calcium/H2O2 as inductors. In Fig. 4A, the maximum
mitochondrial swelling induced by phosphate and calcium is rep-
resented by a decrease in absorbance. When mitochondria were
incubated with SYD-1, a reduction of swelling by approximately
12%, 22% and 30% was observed in comparison to the control for
the concentrations 0.50, 0.75 and 1.0 lmol of SYD-1 by mg of pro-
tein, respectively. When calcium/H2O2 were used as inducers
(Fig. 4B), the mesoionic compound inhibited swelling slightly,
reaching approximately 12% inhibition at the highest concentra-
tion used (1.0 lmol mg1 protein).3.5. Effect of SYD-1 on the mitochondrial NADPH redox state
NADPH acts as a co-enzyme for at least two important antioxi-
dant enzymes in the mitochondria: thioredoxin reductase and glu-
tathione reductase [39]. Only its reduced form emits ﬂuorescence
between 420 and 480 nm, which permits the evaluation of its re-
dox state in mitochondria [40]. In these experiments, alterations
in NADPH signals were observed because the oxidation of NADH
through complex I was inhibited by the addition of rotenone. In
addition, succinate was used as an oxidizable substrate. In Fig. 5,
a small decrease in ﬂuorescence in the absence of calcium is ob-
served, indicating a basal oxidation of NADPH in mitochondria.
After adding calcium (control), an increase in NADPH oxidation is
observed due to oxidative stress induction [40]. In this situation,
the presence of SYD at 0.25, 0.50, 0.75 and 1.0 lmol mg1 protein
promoted the reduction of NADPH oxidation by approximately
11%, 18%, 36% and 48%, respectively.4. Discussion
We previously described the effects of SYD-1 on the energy
linked functions of rat liver mitochondria [13] and suggested that
these functions could be related to mesoionic antitumor activity
[10–11]. In this investigation, we show the effects of SYD-1 on
parameters related to oxidative stress. SYD-1 inhibited iron-in-
duced lipoperoxidation (Fig. 2A), which may be associated with
its uncoupling effect [13]. In fact, this inhibition did not occur
under conditions in which the initiation of lipoperoxidation was
independent of the electron transport chain (Fig. 2B). It is well
known that an increase in the rate of electron transport in the
respiratory chain decreases ROS production [41]. SYD-1 at
1.5 lmol mg1 promoted a ± 4-fold increase in the respiratory rate
during state 4 respiration, an effect comparable to that of proton-
ophore FCCP [13]. Iron induced lipoperoxidation was also inhibited
by MI-D, a different class of mesoionic compound (approximately
97% inhibition from 80 nmol mg1 protein) [42]. Interestingly,
while no inhibition of lipoperoxidation induced by AAPH was
observed with SYD-1 (Fig. 2B), MI-D promoted the inhibition of
lipoperoxidation induced by AAPH (approximately 22% inhibition
from 80 nmol mg1 protein), suggesting that uncoupling capacity
should be a common characteristic of mesoionic compounds. On
the other hand, the absence of SYD-1 effect when AAPH was used
as lipoperoxidation inducer suggests that these mesoionics may
act by distinct mechanisms. It is accepted that mitochondrial
uncoupling can be the mechanism responsible for the antitumor
action of certain compounds [43]. In addition, despite several
studies that consider lipoperoxidation an important inductor of
cell death by apoptosis [44], some studies indicate that protection
of this process may prevent the development of tumors associated
with oxidative stress [45–46]. This fact may represent an impor-
tant differential in the antitumor activity of SYD-1, which also pos-
sesses O2 scavenging ability similar to that of another mesoionic
Fig. 4. Effects of SYD-1 on mitochondrial permeability transition. (A) The incubation system containing 250 mM D-mannitol, 10 mM HEPES (pH 7.2), 0.3 mM potassium
phosphate, 40–50 lM CaCl2, 5 lM rotenone and 0.5 mg mL1 protein was kept at 28 C. Swelling was initiated by the addition of 3 mM potassium succinate in the absence
(control) or presence of SYD-1 at the concentrations indicated or in the presence of 1 mM EGTA. The traces are representative of three independent experiments. (B) The
incubation system containing 250 mM D-mannitol, 10 mM HEPES (pH 7.2), 40–50 lM CaCl2 (except where indicated in the legend) and 0.5 mg mL1 protein was maintained
at 28 C. The swelling was initiated by the addition of 3 mM potassium succinate and 5 lM H2O2 in the absence (control) or presence of indicated concentrations of SYD-1.
The traces are representative of three independent experiments.
Fig. 5. Effects of SYD-1 on the oxidation of mitochondrial NADPH. The incubation system containing 125 mM sucrose, 65 mM KCl, 10 mM HEPES–KOH (pH 7.4), 2.5 lM
rotenone, 1 mg mL1 mitochondrial protein and 45–50 lM CaCl2 was kept under stirring conditions at 30 C. The reaction was triggered with 5 mM potassium succinate and
monitored for 10 min. at 366 nm excitation and 450 nm excitation in the absence (control) and presence of SYD-1 at the concentrations indicated. Values are expressed as
arbitrary ﬂuorescence units (AU) and the traces are representative of three independent experiments.
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in this work (Fig. 3), although weak, may also have contributed to
the strong inhibition of iron-induced lipoperoxidation that we ob-
served. This property of SYD-1 could be important to its clinical
use, as the generation of free radicals may represent a limiting fac-
tor to the use of antineoplastic agents [47].
Considering that oxidative stress may be a consequence of a de-
crease in antioxidant defenses or an increase in ROS level, the ab-
sence of SYD-1 effect on Mn-SOD and CAT (data not shown)
reinforce the fact that its antioxidant properties are primarily
due to the modulation of ROS production. This is in agreement with
the absence of inhibition by SYD-1 of AAPH-induced lipoperoxidation,
when compared with iron-induced lipoperoxidation, suggesting
that SYD-1 has an effect on the initiation of lipid peroxidation.In the present study, the consequences of redox alterations pro-
moted by SYD-1 on the formation/opening of PTP, an important
promoter of apoptosis [17], were also shown using calcium/phos-
phate and calcium/H2O2 as inducers. Both systems of PTP induction
promote an increase in ROS levels which is recognized as a primary
factor for PTP opening/formation due to the oxidation of its constit-
uents [38]. The common component in these systems, calcium, in-
creases ROS formation by several mechanisms, including its
interaction with cardiolipin, which may alter the permeability of
the inner mitochondrial membrane and promote electron leakage
[48]. Meanwhile, H2O2 and phosphate were used with the aim of
amplifying the oxidative stress and PTP formation [48–49]. It is
known that H2O2 in the presence of iron released from iron–sulfur
proteins leads to OH production [40] and consequently induces
186 G.J. Gozzi et al. / Chemico-Biological Interactions 205 (2013) 181–187the formation of PTP in the presence of Ca2+ [48], while Pi increases
oxidative stress for PTP formation by forming reactive aldehydes
[50]. The distinct mechanisms of swelling ampliﬁcation promoted
by H2O2 and Pi are reﬂected on the different shapes of the lines
(Fig. 4). It can be seen that the swelling induced by the presence
of calcium/H2O2 (Fig. 4B) occurs more slowly when compared with
calcium/phosphate, as previously described [51]. Besides this ki-
netic difference between the inducer systems, SYD-1 was able to
protect the mitochondrial swelling in both cases, although not at
the same intensity. The protection provided by SYD-1 against cal-
cium/phosphate-induced swelling (Fig. 4A) may be initially inter-
preted as a consequence of its uncoupling effect, which could
prevent calcium uptake. In addition, decreases in levels of O2
and consequently of H2O2 are also expected. The small effect of
SYD-1 shown when calcium/H2O2 were used as swelling inducers
(Fig. 4B), in comparison to the use of calcium/phosphate
(Fig. 4A), suggests that a decrease in calcium uptake is not the only
means by which SYD-1 inhibited the formation of PTP. As men-
tioned, H2O2 in the presence of iron released from iron-sulfur pro-
teins leads to OH production [40], which is essential for the
production of OH by the Fenton reaction [35]. Thus, the produc-
tion of OH could have been prevented. Finally, the O2 scavenging
performed by SYD-1 may also contribute to this effect.
It is also important to consider the possibility that SYD-1 can
interact with the mitochondrial membrane, preventing the release
of iron. This interaction was previously suggested in experiments
examining swelling induced by valinomycin-K+ in deenergized
mitochondria; in these experiments SYD-1 was able to decrease
the amplitude of the swelling [13]. As SYD-1 can easily react with
nucleophilic groups [10–11], it could also react with membrane
proteins, which are present in large amounts in the structures
[52]. Another possibility is that because of its hydrophobicity,
SYD-1 is able to enter the bilayer and alter its ﬂuidity, as observed
in different classes of mesoionic compounds such as MI-J, MI-4F and
MI-2,4-diF [53]. The capacity of SYD-1 to scavenge OH cannot be
excluded. Although the formation/opening of PTP is a known apop-
tosis trigger, the induction of tumor cell death may also be a result
of the closing of PTP, as observed in cyclosporin A-induced lym-
phoma P-388 death cell [54].
During calcium overload in mitochondria, there is an increase in
O2 formation [48] that might indirectly result in NADPH oxida-
tion. SYD-1 was able to protect NADPH oxidation (Fig. 5), which
is according to inhibition of iron-induced lipoperoxidation and its
O2 scavenging ability. It is well known that NADPH oxidation is
involved in the formation/opening of PTP [55].
In conclusion, SYD-1 demonstrates antioxidant properties in
isolated rat liver mitochondria including inhibition of: lipoperoxi-
dation, formation/opening of PTP and oxidation of NADPH. These
effects seem to be consequences of its uncoupling action and
O2 scavenging ability and could represent a differential mecha-
nism of its antitumor action.
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